# Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis

> **NCT04976140** · PHASE1,PHASE2 · COMPLETED · sponsor: **Paean Biotechnology Inc.** · enrollment: 9 (actual)

## Conditions studied

- Polymyositis
- Dermatomyositis

## Interventions

- **BIOLOGICAL:** PN-101

## Key facts

- **NCT ID:** NCT04976140
- **Lead sponsor:** Paean Biotechnology Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-15
- **Primary completion:** 2023-10-06
- **Final completion:** 2023-10-06
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2024-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04976140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04976140, "Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04976140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*